Predicting Onset and Continuity of Patient-Reported Symptoms in Patients Receiving Immune Checkpoint Inhibitor (ICI) Therapies Using Machine Learning. acmcr. 2020;4(3):344-351. Accessed September 11, 2026. https://fortunejournals.org/ojs/index.php/acmcr/article/view/22321